ArticleWorld journal of microbiology & biotechnology2014
Current biotechnological applications of the genus Amycolatopsis.
Article in World journal of microbiology & biotechnology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- Characterization of ancient DNA preservation in copper-patinated human bone and tooth samples from Latvia.Microbiology spectrum · 2025Article
- Biodegradation of paracetamol by Amycolatopsis sp. Poz 14.BMC research notes · 2025Article
- Advances in vanillin synthesis: focusing on microbial synthesis pathways and prospects.World journal of microbiology & biotechnology · 2025Review
- Microbial survival strategies in desiccated roots ofFrontiers in microbiology · 2025Article
- New insights into the relationship between the average nucleotide identity and the digital DNA-DNA hybridization values in the genusFrontiers in microbiology · 2024Article
- Characterization of the Non-rhizobial Bacterial Community in the Nodule-Associated Soils of Akebono Soybeans and Isolation of Antibiotic ProducingIndian journal of microbiology · 2022Article
- Article
- Looking Back toAntibiotics (Basel, Switzerland) · 2021Review
- Secondary Metabolites of the GenusMolecules (Basel, Switzerland) · 2021Review
- Revisiting the Taxonomic Status of the Biomedically and Industrially Important GenusFrontiers in microbiology · 2018Article
- Comparative Genomics and Biosynthetic Potential Analysis of Two Lichen-IsolatedFrontiers in microbiology · 2018Article
- Legacy effects of continuous chloropicrin-fumigation for 3-years on soil microbial community composition and metabolic activity.AMB Express · 2017Article
- Conjugation of ϕBT1-derived integrative plasmid pDZL802 in Amycolatopsis mediterranei U32.Bioengineered · 2017Article
- Bacillus aryabhattai BA03: a novel approach to the production of natural value-added compounds.World journal of microbiology & biotechnology · 2016Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Recently there has been increasing interest in possible biotechnological applications of the bacterial genus Amycolatopsis. This genus originally attracted attention for its antibiotic producing capabilities; although it is actually a multifaceted genus and a more diverse range of studies involving biotechnological processes have now been undertaken. Several works have demonstrated that the versatility shown by these bacteria is valuable in industrial applications. Here, we provide a condensed overview of the most important biotechnological applications such as bioremediation, biodegradation and bioconversion, as well as aspects that need to be explored further in order to gain a fuller insight into this genus, including its possible potential in the production of biofuel. Antibiotic production is not discussed since this is well covered by the latest edition of Bergey's Manual of Systematic Bacteriology. To our knowledge this is the first report highlighting the versatility and biotechnological potential of the genus Amycolatopsis.
Indexed as
Identifiers
24557749What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.